Company Overview and News

 
‘America First’ risks making US assets a costly last resort

2018-08-23 malaymail
NEW YORK, Aug 23 — America First seems to have become an investment theme by default, as money managers turn to the US in a fraught global environment. The danger is that these flows may be concealing risks in the world’s safe haven.
ABDNY IFK IFX ADN ABDNF

11
Standard Life Aberdeen bosses defend tie-up as £16bn flows out the door

2018-08-07 telegraph.co.uk
The bosses of Standard Life Aberdeen have defended the rationale behind their £11bn merger as billions of pounds continues to head for the door.
SLFPF LLOY ADN SL LYG ABDNY LLPH LLPK LLPJ LLPE LLOBF LLPD LLPG LLDTF LLD5 LLD7 LLPC LLD6 LLD1 ABDNF LLD2 SLFPY

 
Deepak Parekh: HDFC investors voted against me due to directorship in many firms

2018-08-01 livemint
Mumbai: Deepak Parekh, the chairman of mortgage lender Housing Finance Development Corp. Ltd (HDFC), said that the company’s investors had voted against his reappointment on the recommendation of a US proxy advisory firm, which cited his directorship in many listed companies as one of the reasons for negative voting. In an exclusive interview with Mint, Parekh said that Institutional Shareholder Services LC (ISS), the proxy advisory firm which had asked HDFC shareholders to vote against his reappointment, had made similar recommendations in the past as well.
ABDNY VED ADN 500850 ABDNF INDHOTEL

11
Outflows Rock Fund Managers as Europe's $1 Trillion Dream Fades

2018-07-31 theedgemarkets
(July 31): Asset managers across Europe have long had their work cut out, with margins being squeezed and regulations pushing up costs. Now add this to their headaches: client redemptions.
HRGLY DB ADN SL AMUN HL LLOBF ABDNF SLFPF LLOY JUP LYG MORN ABDNY LLPH LLPK LLPJ LLPE LLPD LLPG HRGLF LLDTF LLD5 LLD7 LLPC LLD6 LLD1 LLD2 SLFPY

9
Royce, Ellsworth And India

2018-07-30 seekingalpha
In a July 2 article, "Screening Closed End Funds," I shared my strategy for adding up to 5 closed end funds to the portfolio. Seven CEFs were identified for my watchlist, including:
IFN MNXCZ GBL DISH ADN RMT MLAB RVT.WI ABDNY HEI.A KWR FLIR HEI MSFT MS RVT ABDNF

 
City veteran Anne Richards quits M&G for top Fidelity job ahead of Pru overhaul

2018-07-27 telegraph.co.uk
City veteran and former nuclear physicist Anne Richards has quit M&G Investments for the top job at Fidelity International amid a raft of management changes.
ABDNY ADN ABDNF

17
Culp: Soft Products In A Tough Industry

2018-06-18 seekingalpha
Culp’s long-standing track record and first-rate product quality are why they have a leading market share among home-wear fabrics producers in North America.
H UFI ICHGF ADN IHG DTK HVT.A ETH ABDNY IHG CFI HVT CULP HLT ABDNF

10
Asset managers' cost pressures help Alpha to 'most successful' year

2018-06-06 telegraph.co.uk
The boss of one of the financial services industry's most active consultants said it is benefiting from cost pressures on UK asset managers, but it isn't seeing much impact from new regulations in the sector.
ABDNY SLFPF ADN SL ABDNF SLFPY

10
Phoenix unveils £950m rights issue to fund Standard Life Aberdeen deal 

2018-05-30 telegraph.co.uk
Life insurer Phoenix Group has unveiled a £950m rights issue so that it can snap up the majority of Standard Life Aberdeen's insurance business.
ABDNY SLFPF ADN SL ABDNF SLFPY

49
Tricadia Capital Sees Assets Halved, Managers Depart - Bloomberg

2018-05-17 bloomberg - 3
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
ABDNY BGX ADN BGLF BX ABDNF BGB

6
Voting With Cash, Investors Lose Faith in Erdogan Economy - Bloomberg

2018-05-16 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
ABDNY ADN ABDNF

61
Argentina requests $43 billion IMF credit line

2018-05-09 nzherald.co.nz
Argentina asked the International Monetary Fund for financing to help stem a five-month-rout in the peso that is sparking a surge in interest rates and threatening to derail the country's economic recovery.
JBK GSC ADN TFG GSJ GS ABDNY GLSSP GJS ABDNF

6
Brazil BRF board supports candidate list

2018-04-20 reuters
SAO PAULO, April 20 (Reuters) - The board of Brazilian food company BRF SA has endorsed a list of 10 candidates ahead of a vote on a new set of directors, the company said on Friday, suggesting top shareholders have reached a consensus on its composition.
ABDNY ADN ABDNF

6
Carney Takes on Markets With Shock Warning on BOE Rate View - Bloomberg

2018-04-20 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
ABDNY ADN ABDNF

6
UPDATE 1-Shareholder of Brazil's BRF says board battle hurting business

2018-04-17 reuters
SAO PAULO (Reuters) - A major shareholder in embattled food processor BRF SA said on Tuesday that talks among investors to agree on candidates for the company’s board have stalled, with a prolonged leadership struggle damaging plans for a turnaround.
ABDNY ADN ABDNF

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

CUSIP: 000003128